| Life
Sciences Drew Bulk of CT Venture Capital Last Year
Of the venture capital
invested in Connecticut companies in 2007, more than three
quarters was attracted by life sciences companies, according
to a CURE analysis of MoneyTree™ reports from
PricewaterhouseCoopers and the National Venture Capital
Association, based on data provided by Thomson Reuters.
"Life Sciences" includes Biotechnology and Medical
Devices & Equipment. Details are as follows.
CT Venture Capital
Investments by Year
|
Year
|
# of Deals
|
Investment
Amount
|
Life
Sciences Amount
|
% Life Sciences
|
| 2007 |
33
|
$266.0
million
|
$209.2
million |
77% |
| 2006 |
31
|
$263.9
million
|
$161.6
million |
61% |
|
2005
|
31
|
$192.8
million
|
|
|
|
2004
|
32
|
$195.9
million
|
|
|
|
2003
|
34
|
$203.8
million
|
|
|
|
2002
|
38
|
$182.7
million
|
|
|
| 2001 |
70
|
$549.8
million
|
|
|
CT Venture Capital
Investments by Quarter
|
Quarter
|
# of Deals
|
Investment
Amount
|
Life
Sciences Amount
|
% Life Sciences
|
| Q1
2008 |
8 |
$36.1
million |
$21.0
million
|
58%
|
| Q4 2007 |
10 |
$75.6
million
|
$61.3
million
|
81%
|
| Q3 2007 |
8 |
$37.8
million
|
$20.1
million
|
53%
|
| Q2 2007 |
8 |
$102.8
million
|
$83.8
million
|
82%
|
| Q1 2007 |
7 |
$
49.8 million
|
$44.2
million
|
89%
|
| Q4 2006 |
6 |
$39.3
million
|
$20.1
million
|
52%
|
|
Q3 2006
|
10
|
$56.4
million
|
$21.5
million
|
38%
|
|
Q2 2006
|
9
|
$111.7
million
|
$68.7
million
|
62%
|
|
Q1 2006
|
6
|
$56.6
million
|
$51.3
million
|
91%
|
CT Life Science Venture
Capital Investments by Type
|
|
2006
|
2007
|
2008
Q1
|
|
|
Deals
|
$
|
Deals
|
$
|
Deals
|
$
|
|
Biotech
|
9
|
146,600,800
|
8
|
118,250,100
|
2
|
21,000,000
|
|
Medical
Devices
|
2
|
15,000,000
|
6
|
67,332,000
|
0
|
0
|
|
Other*
|
|
|
1 |
23,655,000 |
|
|
|
TOTAL
(Life Sciences)
|
11
|
161,600,800
|
15
|
209,237,100
|
2
|
21,000,000
|
* RainDance Technologies of
Guilford
CT Life Science Venture
Capital Investments: Detail by Quarter and Type
|
|
|
Company
|
$
|
|
2008
Biotech
|
Q1
|
Pequot
EnzymeRx
|
14,000,000
|
|
2008
Biotech
|
Q1
|
Affomix
|
7,000,000
|
|
Total
Q1
|
|
|
21,000,000
|
|
|
|
|
|
|
2007
Biotech
|
Q1
|
RainDance
Technologies
|
23,655,000
|
|
2007
Biotech
|
Q1
|
Cara
Therapeutics
|
5,000,000
|
|
2007
Biotech
|
Q2
|
Spine
Wave
|
45,000,200
|
|
2007
Biotech
|
Q2
|
BioRelix
|
25,750,200
|
|
2007
Biotech
|
Q3
|
Optherion
|
10,000,000
|
|
2007
Biotech
|
Q3
|
Genomas
|
2,500,000
|
|
2007
Biotech
|
Q3
|
REN
Pharmaceuticals
|
1,000,000
|
|
2007
Biotech
|
Q4
|
Optherion
|
26,999,700
|
|
2007
Biotech
|
Q4
|
Carigent
Therapeutics
|
2,000,000
|
|
Total
Year
|
|
|
141,905,100
|
|
|
|
|
|
|
2007
Medical Devices
|
Q1
|
Stevens
Proof of Concept
|
500,000
|
|
2007
Medical Devices
|
Q1
|
Applied
Spine Technologies
|
15,000,000
|
|
2007
Medical Devices
|
Q2
|
Applied
Spine Technologies
|
13,000,000
|
|
2007
Medical Devices
|
Q3
|
HistoRx
|
6,552,000
|
|
2007
Medical Devices
|
Q4
|
Ikonisys
|
20,000,000
|
|
2007
Medical Devices
|
Q4
|
HistoRx
|
2,280,000
|
|
Total
Year
|
|
|
67,332,000
|
| Total
2007 Life Science |
|
|
209,237,100 |
|
